State Of Tennessee, Treasury Department Protagonist Therapeutics, Inc Transaction History
State Of Tennessee, Treasury Department
- $25.5 Billion
- Q1 2025
A detailed history of State Of Tennessee, Treasury Department transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, State Of Tennessee, Treasury Department holds 26,485 shares of PTGX stock, worth $1.44 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
26,485
Previous 27,076
2.18%
Holding current value
$1.44 Million
Previous $1.05 Million
22.49%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PTGX
# of Institutions
307Shares Held
62MCall Options Held
834KPut Options Held
555K-
Farallon Capital Management LLC San Francisco, CA6.11MShares$333 Million1.7% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$314 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.72MShares$312 Million4.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.36MShares$238 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3MShares$164 Million5.07% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.68B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...